Ethical Considerations in Clinical Trials for Rare Genetic Diseases: The Case of Huntington’s Disease

American Journal of Bioethics 23 (7):94-96 (2023)
  Copy   BIBTEX

Abstract

Research and clinical trial development for rare diseases pose unique bioethical challenges. Much of the literature on rare diseases focuses on patient advocacy and drug development to manage or cu...

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,075

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Genetic testing of children for late onset disease.Mary Ann Sevick, Donna G. Nativio & Terrance Mcconnell - 2005 - Cambridge Quarterly of Healthcare Ethics 14 (1):47-56.
Genetic Testing of Children for Late Onset Disease.Mary Ann Sevick, Donna Nativio & Terrance Mcconnell - 2005 - Cambridge Quarterly of Healthcare Ethics 14 (1):47-56.
Rare Disease Research.Francesc Palau & Carmen Ayuso - 2023 - In Erick Valdés & Juan Alberto Lecaros (eds.), Handbook of Bioethical Decisions. Volume I: Decisions at the Bench. Springer Verlag. pp. 123-143.
Orphan Tests.Leslie G. Biesecker - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (2):300.
What makes placebo-controlled trials unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.

Analytics

Added to PP
2023-06-22

Downloads
9 (#1,256,001)

6 months
6 (#524,433)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations